Figure 3.
Bar plots of comparisons of significant gene alteration frequency of GEPNEC and local adenocarcinoma patients. GEPNEC, gastroenteropancreatic neuroendocrine carcinoma. *, P<0.05; **, P<0.01.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.